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PROLIFERATION OF VASCULAR smooth muscle cells is a prominent feature of atherosclerosis and of restenosis following angioplastic injury (32, 34) . Similarly, proliferation of the smooth muscle-like mesangial cell is central to experimental and clinical glomerulonephritis (3, 15, 33) . Thus both vascular smooth muscle and mesangial cells are potential targets for antiproliferative therapeutic intervention, and both have occasioned numerous studies on factors involved in regulating their proliferation. Heparin is well known to inhibit smooth muscle cell proliferation in vivo and under cell culture conditions (4, 6, 29, 41) and to suppress smooth muscle cell migration (16, 17, 28) . These effects of exogenously administered heparin may reflect physiological properties of endogenous heparan sulfate molecules (17, 37) , providing further impetus for studying the mechanisms involved. Numerous signal transduction mechanisms have been implicated as potentially contributing to the antiproliferative phenomenon (7, 21, 29, 30) , but no single definitive mechanism has been established. Both protein kinase C-dependent MAPK signaling and MAPK-independent signals associated with cell cycle entry and immediate-early response gene induction are inhibited by heparin in mesangial cells (21) . Among non-MAPK signals shown to be heparin sensitive, Ca 2ϩ /calmodulin-dependent protein kinase (CaMK) activity has been studied in cultured rat mesangial (20) and aortic smooth muscle (23) cells.
The CaMKs are a family of calmodulin-dependent kinases with a variety of substrates that serve to integrate Ca 2ϩ signaling within the cell (8, 13, 14) . Calmodulin binds Ca 2ϩ to form the active Ca 2ϩ /calmodulin complex. Four CaMKs have been described (13, 14) ; CaMK-II is unique in being autoregulatory. On binding Ca 2ϩ /calmodulin, it undergoes autophosphorylation in a complex that then retains activity, until dephosphorylated, independently of calmodulin. This calmodulin-independent activity is referred to as autonomous activity. CaMK-II has been identified in mesangial cells by Western blotting (40) , and it has been linked to c-fos induction in several cell lines (1, 24) , including mesangial (40) and vascular smooth muscle (23) cells. It may thus be important for unwanted proliferation in these cells, and indeed it has been found that heparin does not inhibit CaMK-II in vascular smooth muscle cells selected for heparin resistance (i.e., that continue to proliferate in the presence of heparin) (23) . Further linking CaMK-II to proliferation are observations that its inhibition suppresses cyclin D1 expression (25) and blocks cells in late G 1 (25, 36) and that it is required for progression of oocytes through G 2 /M (19) .
We demonstrated that heparin suppresses autonomous CaMK activity and CaMK signaling to induce c-fos in mesangial cells (20) . However, heparin added to an in vitro CaMK assay was without effect (20) , indicating that its effects on the CaMK pathway are mediated through other cellular components or at a level other than direct inhibition of autonomous CaMK-II. Furthermore, heparin was without effect on expression of total CaMK kinase activity elicited in vitro by addition of excess Ca 2ϩ and calmodulin to cell extracts, suggesting inhibition is not at the level of calmodulin. Mishra-Gorur et al. (23) confirmed inhibition of CaMK-II activity in vascular smooth muscle cells and demonstrated a decreased phosphorylation of CaMK-II immunoprecipitates in the presence of heparin. Using phosphatase inhibitors, they proposed activation of protein phosphatases PP-1 and PP-A2 by heparin (23) . Indeed, activation of phosphatases is an interesting hypothesis to account for heparin's suppressive effects on multiple, disparate kinase pathways. However, we recently showed that the decrease in serum-stimulated Erk MAPK activity that occurs in the presence of heparin is not dependent on activity of the Erk regulatory phosphatases (43) . In particular, activity of the MAPK phosphatase-1 (MKP-1), a primary regulator of Erk in smooth muscle cells (9, 18) , is actually decreased in the presence of heparin, apparently secondarily to a decrease in Erk-dependent MKP-1 induction (43) . Therefore, if a unifying mechanism exists to explain heparin's effects on multiple kinases, it may lie elsewhere than in phosphatase activation. The present study was undertaken, in part, to determine the role decreased phosphorylation may play in heparin's suppression of CaMK-II activity and c-fos induction.
MATERIALS AND METHODS
Materials. FBS, heparin (bovine lung, lot no. 49H0648 used in all experiments), chondroitin and dermatan sulfates, cAMP, phosphodiesterase (PDE), trifluoperazine, and malachite green were all obtained from Sigma (St. Louis, MO). RPMI-1640 cell culture medium, trypsin, Trizol reagent, and LipoFectamine 2000 were from Invitrogen Canada (Burlington, Ontario). NuSerum IV (BD Biosciences, Mississauga, Ontario) was used as the stimulus wherever serum stimulation of quiescent cell cultures is referred to. Calmodulin, ionomycin, and the CaMK-II inhibitor KT-5926 were products of Calbiochem (San Diego, CA). Autocamtide-2 was from Bachem (Torrance, CA). ECL Plus Western blotting kits, nitrocellulose, and Hybond-N membranes were purchased from Amersham Biosciences (Baie D'urfé, Quebec). SR␣ plasmids containing either the coding sequence for the first 326 amino acids of the native sequence of CaMK-II␣, designated CaMK-II␣326 and containing regulatory and catalytic domains, or coding a constitutively active mutant of 326 amino acids with a T286D replacement, were kindly provided by Dr. Howard Schulman (11) . Anti-CaMK-II␣ antibody (mouse monoclonal IgG1, cat. no. 05-532) was from Upstate (Charlottesville, VA). Anti-phospho-Thr antibody was from Santa Cruz Biotechnology (Santa Cruz, CA) and an antibody to phospho-Thr286-CaMK-II (rabbit polyclonal, cat. no. 44 -674G) was a product of BioSource (Camarillo, CA).
Cell culture and transfection. Rat mesangial cell cultures were established and characterized as previously described (38) . They were maintained in RPMI 1640 medium with 10% FBS, in a humidified atmosphere of 5% CO 2 at 37°C, and subcultured by trypsinization. Experiments were performed on cells between passages 5 and 15, as described previously (20) . For transfection, cells were passaged at a split ratio of 1:3 and grown to ϳ80% confluence. Four micrograms of plasmid DNA per 10-cm plate (either empty vector SR␣, vector coding CaMK-II␣ 326, or the T286D mutant) were diluted with serumand antibiotic-free RPMI-1640 and incubated for 5 min before addition of the lipofectamine reagent at a ratio of DNA:lipofectamine of 1:2-1:3 (wt/wt). The mixture was incubated for 15 min at room temperature and then overlaid onto prewashed mesangial cell layers. After incubation at 37°C for 5-6 h, the cells were returned to 10% FBS medium and grown overnight before serum deprivation (0.4% for 48 h) and subsequent stimulation with NuSerum or ionomycin.
Western blotting. For detection of total CaMK-II, cells were washed with chilled phosphate-buffered saline and lysed by two freeze-thaw cycles in 50 mM HEPES buffer containing 0.5% Nonidet P-40, containing protease and phosphatase inhibitors (1 mM Na 3VO4, 25 mM NaF, 1 mM PMSF, and 1 g/ml each of aprotinin, leupeptin, and pepstatin). They were then sonicated twice for 5 s at 200 W and centrifuged (13,400 g, 15 min). Cell extracts were separated by 12% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Membranes were blocked with 5% nonfat dry milk in TBS and blotted overnight with 1 g/ml anti-CaMK-II␣ at 4°C. After being washed twice with water, membranes were blotted with horseradish peroxidase-conjugated rabbit anti-mouse IgG for 90 min at room temperature, washed twice with water, three times with TBS containing 0.01% Tween 20, and visualized with ECL Plus reagent according to the manufacturer's protocol.
For phospho-Thr286-CaMK-II, cells were lysed in modified RIPA buffer (10 mM Tris, pH 7.4, with 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 20 mM Na 4P2O7, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 10% glycerol, 1 mM PMSF, 60 g/ml aprotinin, 10 g/ml leupeptin, 1 g/ml pepstatin, 1 mM NaF, and 2 mM Na 3VO4). Thirty micrograms of total protein were separated by 10% PAGE, transfered to polyvinyl difluoride membrane, and blocked in TBS with 0.1% Tween and 5% BSA. Overnight incubation with a 1:1,000 dilution of anti-phospho-Thr286 was followed by incubation with a 1:7,500 dilution of secondary antibody and visualization with ECL Plus reagent. Dephosphorylation was achieved by incubating cell lysates (30 g total protein prepared without vanadate) with 400 units of phosphatase in phosphatase buffer (50 mM Tris, pH 7.5, with 1 mM EDTA, 5 mM DTT, and 2 mM MnCl 2) for 30 min at 30°C before 10% SDS-PAGE.
Detection of c-fos mRNA expression by Northern blotting. Total RNA was isolated with Trizol reagent and 10 g of total RNA were loaded on a 1.2% agarose/2.2 M formaldehyde gel, transferred to Hybond-N membrane overnight, and hybridized with a [␣-
32 P]dCTPlabeled c-fos fragment as before (42) . The hybridization solution contained 50% formamide, 10% dextran sulfate, and 1% SDS. Membranes were washed with 2ϫ SSC/0.1% SDS twice at room temperature for 10 min, twice at 50°C for 15 min, and then in 0.1ϫ SSC/0.1% SDS twice at 50°C for 30 min before exposure to Kodak MS X-ray film.
Kinase activity assay. Autonomous CaMK activity and total activity were measured as described previously (20) . Briefly, total cell proteins were harvested in lysis buffer as above for Western blotting and centrifuged (13,400 g, 15 min). For autonomous activity, 5-10 g of lysate protein were incubated at 30°C for 3 min in 25 l of 50 mM HEPES assay buffer containing 10 mM MgCl2, 0.1 mM ATP, 1 mM EGTA, 0.02 mM autocamtide peptide (KKALRRQETVDAL) as a substrate, and 5 Ci/ml [␥-
32 P]ATP. For total activity, EGTA was replaced by 4 mM CaCl2 and 2 M calmodulin. Reactions were stopped by addition of trichloroacetic acid to 5% and spotted on P81 phosphocellulose filters, washed with 75 mM H3PO4, and counted by liquid scintillation. Immunoprecipitation of phosphorylated protein for kinase assay was carried out with an anti-phospho-Thr antibody. Cell extracts were prepared as for CaMK Western blots and 200 g of total protein were incubated with 1 g antibody overnight a 4°C. After being incubated with 100 l of a 50% slurry of protein G (2 h, 4°C), the pellets were resuspended in equal volume of 2ϫ kinase buffer, incubated at 30°C for 3 min, and loaded on P81 filter paper as above.
Calmodulin activity assay. We adapted a PDE-linked enzyme assay that has been developed for in vitro assessment of calmodulin activity during purification from mucus (10), as this assay has good sensitivity and specificity (5) . To prepare samples, treated cells were placed in 100 l 0.9% NaCl during freeze-thaw cycles, then scraped into 1.5-ml tubes, boiled at 100°C for 5 min, placed on ice for 10 min, and centrifuged at 13,400 g for 15 min at 4°C.
The calmodulin activity assay uses calmodulin-dependent PDE to convert cAMP to AMP with subsequent liberation of inorganic phosphate by alkaline phosphatase. Phosphate is then measured spectrophotometrically (⌬A650) after reaction with malachite green as described (10, 27) . Five micrograms of total cell protein were preincubated with 2 mU of PDE and 1.5 U alkaline phosphatase in 0.8 ml assay buffer without Ca 2ϩ [40 mM Tris/40 mM imidazole (pH 7.4), 1 mM Mg(CH3COO)2] for 1 min at 30°C. After addition of 1 mM cAMP, the assay mixtures were incubated for a further 30 min at 30°C. Fifty-microliter aliquots of assay mixtures were then added to 900 l molybdic acid reagent and mixed with 25 l malachite green solution (1.26 mg/ml). After 2 min, the absorption was measured at 650 nm. Calmodulin activity was calculated based on a standard curve prepared with activated calmodulin.
The response of the malachite green detection component of the assay was linear over a range of potassium phosphate from 0.5 to 3 g, allowing standard curves to be constructed with purified calmod-ulin that were linear (r 2 Ͼ 0.95) over 0 to 125 ng calmodulin and an absorbance range (A650 nm) of 0 to 0.6. Conditions for the initial reaction with cytosolic extracts were chosen to give a final absorption in the range 0.2 to 0.4 (typically, 5 g cell protein). Under these conditions, addition of excess, exogenous Ca 2ϩ caused an approximate doubling of the signal, presumably representing activation of total cellular calmodulin, and the following controls all gave an absorption of less than 0.03: omission of PDE, omission of alkaline phosphatase, omission of cAMP with or without added Ca 2ϩ , and inclusion of EGTA. Furthermore, the Ca 2ϩ -calmodulin antagonist trifluoperazine (1 mM) suppressed the calmodulin standard curve to background absorbance, and standard curves were corrected for background by subtracting values in the presence of trifluoperazine.
Statistical analyses. Statistical differences between groups within an experiment were analyzed by one-way ANOVA with Tukey's post hoc test for pairwise comparisons.
RESULTS
As in our previous studies (20) , treatment of quiescent rat mesangial cells with either serum or ionomycin resulted in a significant increase in autonomous CaMK activity (Fig. 1) that consistently reached about 15-20% of total activity (data not shown). This autonomous activity was partially inhibited by the CaMK-II inhibitor KT-5926 and by heparin (1 g/ml). Endogenous CaMK-II was only weakly detected by Western blotting (Fig. 2) , and to further confirm inhibition of CaMK-II by heparin, we transfected cells with wild-type CaMK-II␣ 326 . The CaMK-II␣ 326 protein was strongly expressed (Fig. 2) , resulted in a higher basal level of CaMK activity in quiescent cells, and was activated by ionomycin (Fig. 1) . Again, both KT-5926 and heparin inhibited ionomycin-dependent activity in the CaMK-II␣ 326 transfectants. Mock transfection with empty SR␣ plasmid did not affect basal CaMK activity or activation of endogenous CaMK-II by serum or ionomycin, compared with untransfected cells (compare black and open bars, Fig. 1 ).
c-fos mRNA is elevated 30 min after ionomycin treatment of quiescent mesangial cells (Fig. 3) . Consistent with c-fos induction through CaMK-II (20), c-fos mRNA levels show the same pattern of response to KT-5926 and heparin as does autonomous CaMK activity; significant inhibition of c-fos expression occurs with each agent, and heparin decreases c-fos mRNA levels to the basal level observed in quiescent cells. Basal c-fos expression is increased in cells transfected with either empty plasmid or with plasmid containing CaMK-II␣ 326 . The c-fos mRNA levels in quiescent cells transfected with the empty plasmid are not significantly affected by ionomycin or inhibitors (data not shown). However, ionomycin increases c-fos mRNA levels further in CaMK-II␣ 326 -transfected cells, and heparin decreases these levels to below basal values (Fig. 3) .
To determine whether heparin acts at a level proximal to CaMK in this signaling pathway, we measured calmodulin activity in control, transfected, and heparin-treated cells. Use of the phosphodiesterase-linked assay with cytosolic extracts is with caveats such as potential activation by Ca 2ϩ release during cell extraction or interference from cellular inorganic phosphate (see DISCUSSION). Nevertheless, we were able to implement the assay in a reproducible manner that allows certain conclusions to be drawn. (Table 1) . Thus the phosphodiesterase-linked assay measures an increase in calmodulin activation in both control and transfected cells that is unresponsive to heparin; the influence of heparin is downstream of calmodulin activation.
An initial event in CaMK-II activation following upstream activation of calmodulin is autophosphorylation on Thr 286 . We used a phospho-Thr 286 -specific antibody to examine whether 1 g/ml heparin interfered with this event. Because higher concentrations of heparin have been reported to decrease net CaMK-II phosphorylation (23), we also compared the effects of 100 g/ml heparin (Fig. 4) . Treatment with phosphatase demonstrates that the antibody recognizes primarily a phosphorylated form of the protein. Heparin at 1 g/ml is ineffective at decreasing ionomycin-dependent phosphorylation of Thr 286 . On the other hand, 100 g/ml heparin significantly decreases phosphorylation, as previously observed (23) .
To further examine the effects of heparin on phosphorylation, we used the alternative approach of measuring CaMK activity in immunoprecipitates prepared with an antibody directed against phosphothreonine. Despite inclusion of phos- phatase inhibitors in the extraction solution, we were unable to achieve reproducible or fully autonomous activity in the immunoprecipitated fractions (data not shown), and we conclude that activated CaMK-II may be unstable under the conditions of immunoprecipitation. As an alternative indicator of CaMK-II phosphorylation, we measured total CaMK activity elicited by addition of Ca 2ϩ and calmodulin in anti-phosphoThr immunoprecipitates (Table 2 ). Ionomycin stimulation increased the CaMK-II activity of anti-phospho-Thr immunoprecipitates by about twofold. Heparin (1 g/ml) was without significant effect, supporting the conclusion that this level of heparin inhibits CaMK-II activity independently of altering its level of phosphorylation. Consistent with decreased phosphorylation in the presence of 100 g/ml heparin, this concentration of heparin decreased recovery of activity in the immunoprecipitate by about 45% (Table 2) .
Because higher concentrations of heparin reduced phosphorylation of Thr286 and decreased recovery of CaMK-II activity in anti-phospho-Thr immunoprecipitates, we compared the effects of 1 and 100 g/ml on c-fos induction. The higher concentration did not give a significantly greater decrease in ionomycin-dependent c-fos induction than the lower (Fig. 5) . We previously showed that 1 g/ml heparin is sufficient to Values are means Ϯ SD from 3 independent experiments. Activity was measured as described in MATERIALS AND METHODS, in extracts of untransfected cells or of cells transfected with empty SR␣ plasmid or with wild-type CaMK-II␣326 or T286D mutant. Treatments with 5% serum, 1 M ionomycin, or 1 M ionomycin with 1 g/ml heparin were as in Fig. 1 . When 10.0 ng activated calmodulin (Ca 2ϩ replete) were added to lysis buffer without cell extract and carried through the assay procedure, the apparent recovery was 9.80 Ϯ 1.19 ng. Different from quiescent cells in the same row, *P Ͻ 0.05 and †P Ͻ 0.02.
cause near-maximal suppression of [ 3 H]thymidine incorporation in stimulated mesangial cells (38) .
As a further approach to studying the role of phosphorylation in heparin's effect on CaMK signaling, we used a constitutively active phosphomimetic mutant of CaMK-II␣ 326 in which Thr 286 is replaced with Asp, designated CaMK-II␣(T286D). Cells transfected with this mutant expressed 110 Ϯ 40% (n ϭ 7) basal CaMK activity compared with untransfected cells stimulated with serum (Fig. 6A) . This was not significantly increased by ionomycin nor was it decreased by the CaMK-II inhibitor KT-5926, consistent with the autonomous activity reported for this modified protein (11) . However, the activity was significantly decreased by 1 g/ml heparin. Furthermore, quiescent cells expressing CaMK-II␣(T286D) had their basal c-fos mRNA levels decreased to 66.5 Ϯ 17.4% by 15 min of exposure to 1 g/ml heparin (Fig.  6B) . Calmodulin activity was unaffected ( Table 1 ). The 1-g/ml concentration of heparin apparently produces maximal suppression in this model. In three further independent experiments comparing 1 and 100 g/ml heparin in CaMK-II␣(T286D)-transfected cells, heparin again caused a decrease to 63.9 Ϯ 7.7% of basal c-fos expression, and no further decrease was seen with 100 g/ml (Fig. 7) .
The effects observed here also raise the question of specificity. The closely related galactosamine-based glycosaminoglycan chondroitin sulfate had no effect on ionomycin-induced c-fos expression, nor did the even more cosely related iduronic acid-rich dermatan sulfate (Fig. 8) .
DISCUSSION
CaMK-II is a broad-specificity calmodulin-dependent kinase with homology to, but distinct from, CaMK-I and CaMK-IV (14) . The assembled CaMK-II complex (8, 14) consists of 10 -12 subunits representing four different isoforms (␣, ␤, ␥, and ␦), each of which occurs in multiple splice variants. Each has an inhibitory regulatory domain that interacts with the catalytic domain; this interaction is disrupted by Ca 2ϩ /calmodulin to expose the active site. The ␣-subunit is highly conserved among many species. In contrast to other calmodulindependent enzymes, CaMK-II has autophosphorylation sites in the regulatory domain whose phosphorylation breaks the inhibitory interaction of the catalytic domain and confers autonomous activity, i.e., activity independent of Ca 2ϩ or calmodulin (13, 14, 35) . In particular, Thr286 of CaMK-II␣ is essential for autonomous activity; when it is mutated to leucine, the kinase remains ligand (calmodulin) dependent (11), like myosin light chain kinase (MLCK). Mutation of Thr 286 to the phosphomimetic aspartate confers constitutive activity of about 10 -20% that of native autonomous protein (2), as exploited in (1 g/ml) 96.3Ϯ28.9 Ionomycin ϩ heparin (100 g/ml)
57.0Ϯ23.3
Values are means Ϯ SD from 5 independent experiments. Quiescent mesangial cells were treated with ionomycin with or without heparin at either 1 g/ml or 100 g/ml as indicated. Total CaMK-II activity is expressed relative to the value with ionomycin stimulation taken as 100%. *Different from 1 g/ml heparin (P Ͻ 0.05). †Different from quiescent (P Ͻ 0.01) and from 100 g/ml heparin (P Ͻ 0.05). the present study. Thus phosphorylation of Thr286 is both necessary and sufficient for CaMK-II ativity. Although phosphorylation of other Thr residues occurs, notably Thr305 and Thr 306 , this is inhibitory and prevents activation of the kinase by binding of Ca 2ϩ /calmodulin (12) . Among the numerous substrates of CaMK-II are transcription factors such as cAMP response element-binding protein (CREB), and it is likely through phosphorylation of this factor that its activation induces c-fos (31) . Indeed, ionomycin-induced phosphorylation of CREB on Ser133 is accompanied by c-fos induction in mesangial cells (42) .
We previously suggested that the rapid response of Erk and CaMK signaling to heparin supports a mechanism of action from the cell surface (20, 21, 38) . For instance, internalization of negatively charged heparin by mesangial cells is slow (hours), compared with suppression of a CaMK-II signal 30 s after addition to cultured cells of heparin together with a stimulus such as ionomycin (20) . This is not due to interference with ionomycin-dependent Ca 2ϩ signaling, which is unaffected by heparin in these circumstances (20) . And the effect shows some specificity for heparin; the closely related glycosaminoglycans, chondroitin and dermatan sulfates, are ineffective in suppressing signaling to c-fos. This points to a mechanism of competing signaling, or perhaps to disruption of proximal events at the cell surface, rather than direct interaction of heparin with downstream components of the kinase cascades. Furthermore, because autonomous activity assayed in vitro is decreased in extracts of cells that had previously been exposed to heparin, the inhibition of CaMK-II might involve events at, or upstream of, enzyme assembly and autophosphorylation.
However, the present results appear to rule out this explanation.
In the present study, we could obtain no evidence for an effect of heparin on formation of active Ca 2ϩ /calmodulin. This result must be qualified by the limitations of the assay. Release of Ca 2ϩ from stores during cell disruption could mask true levels of active calmodulin. Alternatively, Ca 2ϩ could dissociate from calmodulin prior to assay. However, we do measure an increase in activity after treatment with ionomycin, which is sensitive to the calmodulin antagonist trifluoperazine. This suggests that activation can be measured with our assay, and the response is not affected by heparin. This is consistent with the earlier observation that heparin does not affect angiotensinmediated mesangial cell contraction (20) , a process also operating through calmodulin-dependent activation of MLCK. Together with ionomycin-dependent phosphorylation of Thr286 in the presence of 1 g/ml heparin, these observations support a mechanism of action of heparin independent of calmodulin.
Activation of phosphatase(s) was proposed as an attractive mechanism whereby heparin might negatively regulate diverse kinase cascades (22) , potentially at multiple sites. Subsequently, Mishra-Gorur et al. (23) presented evidence for decreased phosphorylation of the CaMK-II␦ subunit in vascular smooth muscle labeled with [ 32 P]phosphate and then treated with serum containing 100 or 500 g/ml heparin (49 and 68% decrease, respectively, compared with heparin-free controls). Using several phosphatase inhibitors, which prevented decreased phosphorylation of CaMK-II otherwise occurring in the presence of heparin, they provided evidence for a role of protein phosphatases PP-1 and PP-2A. However, we recently showed that 1 g/ml heparin did not suppress Erk activation by upregulating its phosphatase, MKP-1, but rather decreased MKP-1 secondarily to effects on Erk (43) . In our mesangial cell system, this more physiological concentration of heparin shows near-maximal suppression of [ 3 H]thymidine incorporation (38) and c-fos induction (Fig. 5) . Therefore, we investigated in the present study whether dephosphorylation of CaMK-II was necessary for the effect of heparin at the lower concentration. Although high amounts of heparin did indeed decrease the amount of phospho-CaMK-II, 1 g/ml did not, suggesting that at least some of heparin's antimitogenic activity is not due to effects on protein phosphatases. We also found that immunoprecipitates of phospho-Thr phosphoproteins contained increased amounts of CaMK-II activity following ionomycin stimulation, that was decreased by 100 g/ml heparin (Table 2) , again consistent with the findings of Mishra-Gorur et al. (23) . Heparin at 1 g/ml, on the other hand, was without effect on recovery of activity, indicating that the lower concentration of heparin did not affect total Thr phosphorylation. We can conclude that decreased phosphorylation is not necessary for suppression of CaMK-II activity, and indeed heparin treatment also decreases the constitutive activity of the phosphomimetic mutant T286D, which is not dependent on phosphorylation (at least of Thr286) for enzyme activity. As in control cells, 1 g/ml heparin is as effective as 100 g/ml in decreasing activity of the phosphomimetic T286D mutant. We conclude that heparin must elicit signals that disrupt or prevent an active form of the protein from occurring whether Thr 286 is phosphorylated or not. Because the suppressed activity persists in the assay carried out in vitro in the absence of heparin, it is reasonable to suggest that heparin may rapidly mobilize an inhibitory factor, or alternatively disrupt association with an activating component. The existence of such factors is speculative but suggests models for the more general effects of heparin on signaling that should be evaluated. In this context, it is interesting to note that Src has also been implicated in induction of c-fos through the serum response element, downstream of CaMK-II signaling in mesangial cells (39) , although the nature of the CaMK-II/Src interaction is unknown.
The inhibitor KT-5926 was initially introduced as an inhibitor of MLCK but actually has a lower K i for CaMK-II (0.004 M) than for MLCK (0.018 M). It was shown to act directly at the catalytic site and competitively with ATP (26) . Therefore, it is expected to inhibit CaMK-II␣ 326 as seen in Fig. 1 . That it is not as effective at inhibiting c-fos induction in these transfected cells as it is in untransfected cells (Fig. 3) suggests heparin-sensitive pathways additional to CaMK may be activated in the transfected cells. Alternatively, KT-5926 could have differing inhibitory potencies for autocamtide-2 used as a substrate in assaying autonomous activity and as an endogenous substrate (e.g., CREB) that differ in native protein and truncated recombinant protein. This possibility has not been addressed.
In conclusion, heparin appears to elicit signals that suppress CaMK-II activity independently of phosphorylation of Thr286, although high concentrations of heparin may indeed decrease autophosphorylation of the protein. Activation of calmodulin by Ca 2ϩ is not affected by heparin, and other calmodulindependent proteins such as MLCK may also be unaffected. Whether heparin exploits common mechanisms in regulating CaM kinases and MAP kinases remains to be determined.
